Bookmark
Forward
Sustained clinical response as an endpoint in treatment trials of Clostridium difficile-associated diarrhea.
Stuart Johnson, Dale N Gerding, Thomas J Louie, Nancy M Ruiz, Sherwood L Gorbach
Antimicrobial agents and chemotherapy 2012 Aug
Sizes of these terms reflect their relevance to your search.
No abstract available.
Citation
Stuart Johnson, Dale N Gerding, Thomas J Louie, Nancy M Ruiz, Sherwood L Gorbach.
Sustained clinical response as an endpoint in treatment trials of Clostridium difficile-associated diarrhea.
Antimicrobial agents and chemotherapy.
2012 Aug;56(8):4043-5
Mesh Tags
Aminoglycosides
Anti-Bacterial Agents
Clinical Trials, Phase III as Topic
Clostridioides difficile
Diarrhea
Endpoint Determination
Enterocolitis, Pseudomembranous
Fidaxomicin
Humans
Metronidazole
Polymers
Sulfonic Acids
Treatment Outcome
Vancomycin
Substances
Aminoglycosides
Anti-Bacterial Agents
Polymers
Sulfonic Acids
Metronidazole
Vancomycin
Fidaxomicin
styrenesulfonic acid polymer
PMID: 22615287
View Full Text